Development Generally. As of the Effective Date and subject always to Pfizer’s retained rights to the Patents and Licensed Know-How and the limitations and restrictions set forth herein, Licensee shall have full control, responsibility (financial and otherwise) and authority, at Licensee’s cost and expense, over development, registration, importation, manufacture, and Commercialization of the Licensed Products to be sold or supplied by Licensee in the Territory under this Agreement.
Development Generally. As of the Effective Date and subject always to Shionogi's retained rights to the Patents and Licensed Know-How and the limitations and restrictions set forth herein, Licensee shall have full control, responsibility (financial and otherwise) and authority, at Licensee's cost and expense, over development, registration, importation, manufacture, and Commercialization of the Licensed Products to be sold or supplied by Licensee in the Territory under this Agreement.
Development Generally. After the Research Term and subject to Sections 3.6.2, 5.4.1(a) and (b), 5.4.2 and 5.4.3, Novartis will be solely responsible for conducting, at its sole expense, the Development of its Products as it determines appropriate in its sole discretion.
Development Generally. The Parties’ respective responsibilities for the research and Development of the Product are set forth in this Article 3 and in the Development Plan. Each Party agrees that in performing its obligations under this Agreement (a) it shall comply with all applicable current international regulatory standards, including Good Laboratory Practice, Good Manufacturing Practice and Good Clinical Practice and other rules, regulations and requirements and (b) it will not employ or use any person that has been debarred under Section 306(a) or 306(b) of the US Federal Food, Drug and Cosmetic Act (or similar sanctions in other countries).
Development Generally. As of the Effective Date and subject always to Xxxxxx’s retained rights to the Patents and Licensed Know-How and the limitations and restrictions set forth herein, Licensee shall have full control, responsibility (financial and otherwise) and authority, at Licensee’s cost and expense, over development, registration, importation, manufacture, and Commercialization of the Licensed Products to be sold or supplied by Licensee in the Territory under this Agreement.
Development Generally. Commencing upon the Effective Date and subject to Section 4 and other terms of this Agreement, as between Durect and Alpharma, Alpharma shall be responsible, at its sole Cost, for development of and procuring Regulatory Approval for the Product in the Territory (all such activities the “Development Program”).
Development Generally. Subject to the terms and conditions of this 2013 Construction Coordinating Agreement, including the scheduling of Work in accordance with the Master Project Schedule, the limitations set forth in the Budget and the general scope of services set forth in the CM Agreement, the Parties shall endeavor in good faith to design, construct, operate and use the Project, as contemplated in this 2013 Construction Coordinating Agreement.
Development Generally. (a) The Parties’ respective responsibilities for the research and Development of the Array Compounds and the Products are set forth in this Article 5 and in the Development Plan. All such activities shall be subject to oversight by the JDC.
Development Generally. From and after the Effective Date, subject to the terms and conditions of this Agreement, including the Opt-Out and the ITMN-191 [***], [***] shall assume primary responsibility for and conduct a Development program for the Development of Products as guided by the Development Plan, except as otherwise provided in the ITMN-191[***]. In each [***], [***], through itself or an Affiliate, shall use [***] to Develop Licensed Compound(s).
Development Generally. Developer shall diligently pursue in good faith the development of the Project in general accordance with this Agreement, the information presented as part of the Application and the Project Description. Developer shall further diligently pursue in good faith the satisfaction of the Conditions Precedent. Nothing in this subparagraph shall preclude Developer from exercising its rights of termination as provided in this Agreement.
